These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 31873741

  • 1. Constitutive expression of the cryptic vanGCd operon promotes vancomycin resistance in Clostridioides difficile clinical isolates.
    Shen WJ, Deshpande A, Hevener KE, Endres BT, Garey KW, Palmer KL, Hurdle JG.
    J Antimicrob Chemother; 2020 Apr 01; 75(4):859-867. PubMed ID: 31873741
    [Abstract] [Full Text] [Related]

  • 2. The functional vanGCd cluster of Clostridium difficile does not confer vancomycin resistance.
    Ammam F, Meziane-Cherif D, Mengin-Lecreulx D, Blanot D, Patin D, Boneca IG, Courvalin P, Lambert T, Candela T.
    Mol Microbiol; 2013 Aug 01; 89(4):612-25. PubMed ID: 23782343
    [Abstract] [Full Text] [Related]

  • 3. VanG- and D-Ala-D-Ser-dependent peptidoglycan synthesis and vancomycin resistance in Clostridioides difficile.
    Belitsky BR.
    Mol Microbiol; 2022 Nov 01; 118(5):526-540. PubMed ID: 36065735
    [Abstract] [Full Text] [Related]

  • 4. Histidine kinase-mediated cross-regulation of the vancomycin-resistance operon in Clostridioides difficile.
    Belitsky BR.
    Mol Microbiol; 2024 Jun 01; 121(6):1182-1199. PubMed ID: 38690761
    [Abstract] [Full Text] [Related]

  • 5. AsnB is responsible for peptidoglycan precursor amidation in Clostridium difficile in the presence of vancomycin.
    Ammam F, Patin D, Coullon H, Blanot D, Lambert T, Mengin-Lecreulx D, Candela T.
    Microbiology (Reading); 2020 Jun 01; 166(6):567-578. PubMed ID: 32375990
    [Abstract] [Full Text] [Related]

  • 6. Genomic and expression analysis of the vanG-like gene cluster of Clostridium difficile.
    Peltier J, Courtin P, El Meouche I, Catel-Ferreira M, Chapot-Chartier MP, Lemée L, Pons JL.
    Microbiology (Reading); 2013 Jul 01; 159(Pt 7):1510-1520. PubMed ID: 23676437
    [Abstract] [Full Text] [Related]

  • 7. Genetic characterization of a VanG-type vancomycin-resistant Enterococcus faecium clinical isolate.
    Sassi M, Guérin F, Lesec L, Isnard C, Fines-Guyon M, Cattoir V, Giard JC.
    J Antimicrob Chemother; 2018 Apr 01; 73(4):852-855. PubMed ID: 29346643
    [Abstract] [Full Text] [Related]

  • 8. Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Lower Rates of Initial Cure and Sustained Clinical Response.
    Eubank TA, Dureja C, Garey KW, Hurdle JG, Gonzales-Luna AJ.
    Clin Infect Dis; 2024 Jul 19; 79(1):15-21. PubMed ID: 38382090
    [Abstract] [Full Text] [Related]

  • 9. An operon encoding enzymes for synthesis of a putative extracellular carbohydrate attenuates acquired vancomycin resistance in Streptomyces coelicolor.
    Read N, Howlett R, Smith MCM.
    Microbiology (Reading); 2019 Feb 19; 165(2):208-223. PubMed ID: 30632959
    [Abstract] [Full Text] [Related]

  • 10. Reference Susceptibility Testing and Genomic Surveillance of Clostridioides difficile, United States, 2012-17.
    Gargis AS, Karlsson M, Paulick AL, Anderson KF, Adamczyk M, Vlachos N, Kent AG, McAllister G, McKay SL, Halpin AL, Albrecht V, Campbell D, Korhonen LC, Elkins CA, Rasheed JK, Guh AY, McDonald LC, Lutgring JD, Emerging Infections Program C. difficile Infection Working Group.
    Clin Infect Dis; 2023 Mar 04; 76(5):890-896. PubMed ID: 36208202
    [Abstract] [Full Text] [Related]

  • 11. Role of the msaABCR Operon in Cell Wall Biosynthesis, Autolysis, Integrity, and Antibiotic Resistance in Staphylococcus aureus.
    G C B, Sahukhal GS, Elasri MO.
    Antimicrob Agents Chemother; 2019 Oct 04; 63(10):. PubMed ID: 31307991
    [Abstract] [Full Text] [Related]

  • 12. Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveillance study from 2013 to 2017.
    Karlowsky JA, Adam HJ, Baxter MR, Dutka CW, Nichol KA, Laing NM, Golding GR, Zhanel GG.
    J Antimicrob Chemother; 2020 Jul 01; 75(7):1824-1832. PubMed ID: 32294172
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vitro activity of eravacycline against common ribotypes of Clostridioides difficile.
    Bassères E, Begum K, Lancaster C, Gonzales-Luna AJ, Carlson TJ, Miranda J, Rashid T, Alam MJ, Eyre DW, Wilcox MH, Garey KW.
    J Antimicrob Chemother; 2020 Oct 01; 75(10):2879-2884. PubMed ID: 32719870
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vancomycin-dependent Enterococcus faecalis clinical isolates and revertant mutants.
    Van Bambeke F, Chauvel M, Reynolds PE, Fraimow HS, Courvalin P.
    Antimicrob Agents Chemother; 1999 Jan 01; 43(1):41-7. PubMed ID: 9869563
    [Abstract] [Full Text] [Related]

  • 18. Influence of Binary Toxin Gene Detection and Decreased Susceptibility to Antibiotics among Clostridioides difficile Strains on Disease Severity: a Single-Center Study.
    Costa DVS, Pham NVS, Hays RA, Bolick DT, Goldbeck SM, Poulter MD, Hoang SC, Shin JH, Wu M, Warren CA.
    Antimicrob Agents Chemother; 2022 Aug 16; 66(8):e0048922. PubMed ID: 35861541
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.